359 related articles for article (PubMed ID: 12223128)
1. Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
McCann J; Stockton D; Godward S
Breast Cancer Res; 2002; 4(5):R11. PubMed ID: 12223128
[TBL] [Abstract][Full Text] [Related]
2. The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study.
Maxwell AJ; Beattie C; Lavelle J; Lyburn I; Sinnatamby R; Garnett S; Herbert A
J Med Screen; 2013 Jun; 20(2):91-8. PubMed ID: 24009091
[TBL] [Abstract][Full Text] [Related]
3. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
5. False positive results do not have a negative effect on reattendance for subsequent breast screening.
O'Sullivan I; Sutton S; Dixon S; Perry N
J Med Screen; 2001; 8(3):145-8. PubMed ID: 11678554
[TBL] [Abstract][Full Text] [Related]
6. Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
Castells X; Torá-Rocamora I; Posso M; Román M; Vernet-Tomas M; Rodríguez-Arana A; Domingo L; Vidal C; Baré M; Ferrer J; Quintana MJ; Sánchez M; Natal C; Espinàs JA; Saladié F; Sala M;
Radiology; 2016 Aug; 280(2):379-86. PubMed ID: 26878225
[TBL] [Abstract][Full Text] [Related]
7. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
8. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
[TBL] [Abstract][Full Text] [Related]
10. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
[TBL] [Abstract][Full Text] [Related]
12. Re-attendance at biennial screening mammography following a repeated false positive recall.
Klompenhouwer EG; Duijm LE; Voogd AC; den Heeten GJ; Strobbe LJ; Louwman MW; Coebergh JW; Venderink D; Broeders MJ
Breast Cancer Res Treat; 2014 Jun; 145(2):429-37. PubMed ID: 24748569
[TBL] [Abstract][Full Text] [Related]
13. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
14. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
McGuinness JE; Ueng W; Trivedi MS; Yi HS; David R; Vanegas A; Vargas J; Sandoval R; Kukafka R; Crew KD
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):446-453. PubMed ID: 29382701
[No Abstract] [Full Text] [Related]
16. Specificity of screening in United Kingdom trial of early detection of breast cancer.
BMJ; 1992 Feb; 304(6823):346-9. PubMed ID: 1540731
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
18. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Berg WA; Zhang Z; Lehrer D; Jong RA; Pisano ED; Barr RG; Böhm-Vélez M; Mahoney MC; Evans WP; Larsen LH; Morton MJ; Mendelson EB; Farria DM; Cormack JB; Marques HS; Adams A; Yeh NM; Gabrielli G;
JAMA; 2012 Apr; 307(13):1394-404. PubMed ID: 22474203
[TBL] [Abstract][Full Text] [Related]
19. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
[TBL] [Abstract][Full Text] [Related]
20. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts.
Román M; Hofvind S; von Euler-Chelpin M; Castells X
Br J Cancer; 2019 Jan; 120(2):269-275. PubMed ID: 30563993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
